k Anitviral Molnupiravir interfering in SARSCoV2 replication Illustration of antiviral drug Molnupiravir spheres, centre incorporating itself into SARSCoV2 RNA strand. Molnupiravir is a nucleoside analogue of cytidine and uridine. The drug is inserted into the RNA strand instead of cytidine or uridine. The coronaviruss proofreading enzymes that check for mutations do not recognise Molnupiravir has been inserted instead. This causes RNA polymerase pink to make faulty copies of the faulty RNA strand that can then only code for nonfunctional proteins. Molnupiravir has been approved for use in the UK for patients with moderate to mild Covid19 with other risk factors such obesity, obesity, older age and diabetes mellitus., Photo by RAMON ANDRADE 3DCIENCIASCIENCE PHOTO LIBRARY Stock Photo - Afloimages
Sign up
Login
All images
Anitviral Molnupiravir interfering in SARS CoV 2 replication Illustration of antiviral drug Molnupiravir spheres, centre incorporating itself into SARS CoV 2 RNA strand. Molnupiravir is a nucleoside analogue of cytidine and uridine. The drug is inserted into the RNA strand instead of cytidine or uridine. The coronavirus s proofreading enzymes that check for mutations do not recognise Molnupiravir has been inserted instead. This causes RNA polymerase pink to make faulty copies of the faulty RNA strand that can then only code for non functional proteins. Molnupiravir has been approved for use in the UK for patients with moderate to mild Covid 19 with other risk factors such obesity, obesity, older age and diabetes mellitus., Photo by RAMON ANDRADE 3DCIENCIA SCIENCE PHOTO LIBRARY
RM
Add to Lightbox
Download Comp

Anitviral Molnupiravir interfering in SARS-CoV-2 replication

Illustration of antiviral drug Molnupiravir (spheres, centre) incorporating itself into SARS-CoV-2 RNA strand. Molnupiravir is a nucleoside analogue of cytidine and uridine. The drug is inserted into the RNA strand instead of cytidine or uridine. The coronavirus's proofreading enzymes that check for mutations do not recognise Molnupiravir has been inserted instead. This causes RNA polymerase (pink) to make faulty copies of the faulty RNA strand that can then only code for non-functional proteins. Molnupiravir has been approved for use in the UK for patients with moderate to mild Covid-19 with other risk factors such obesity, obesity, older age and diabetes mellitus., Photo by RAMON ANDRADE 3DCIENCIA/SCIENCE PHOTO LIBRARY

Details

ID
180851649

Collection

License type
Rights Managed

Photographer



More
Top Categories
Editorial
2024 Paris Olympics
Latest News
Latest Sport
Latest Entertainment
2020 Tokyo Olympics
Creative
People and Lifestyle
Sport and Leisure
Business and Technology
Landscape
Animals
Videos
Sport and Leisure
Drone and Timelapse
People and Lifestyle
Business and Technology
Landscape
Sign in
Register
Member access
Login not found.
Forgot Your Password?